State Street Corp First Wave Bio Pharma, Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.62 - $5.86 $51,207 - $483,989
-82,592 Closed
0 $0
Q4 2022

Feb 14, 2023
SELL
$0.46 - $1.15 $0 - $1
-1 Reduced -0.0%
82,592 $72,000
Q3 2022

Nov 15, 2022
BUY
$1.3 - $7.65 $107,370 - $631,836
82,593 New
82,593 $122,000

Others Institutions Holding FWBI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About First Wave BioPharma, Inc.

FWBI Quotes by TradingView
  • Ticker FWBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,562,010
  • Market Cap $2.54M
  • Description
  • First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties; and the biologic ...
More about FWBI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email